Cargando…

Cohort profile: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS)

PURPOSE: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS) is a prospective cohort study in South Africa investigating the association between antiretroviral therapy (ART) use, preterm delivery (PTD) and small-for-gestational age (SGA) live births. PIMS main hypotheses...

Descripción completa

Detalles Bibliográficos
Autores principales: Malaba, Thokozile R, Myer, Landon, Gray, Clive, Newell, Marie-Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487191/
https://www.ncbi.nlm.nih.gov/pubmed/34593488
http://dx.doi.org/10.1136/bmjopen-2020-047133
_version_ 1784577903506227200
author Malaba, Thokozile R
Myer, Landon
Gray, Clive
Newell, Marie-Louise
author_facet Malaba, Thokozile R
Myer, Landon
Gray, Clive
Newell, Marie-Louise
author_sort Malaba, Thokozile R
collection PubMed
description PURPOSE: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS) is a prospective cohort study in South Africa investigating the association between antiretroviral therapy (ART) use, preterm delivery (PTD) and small-for-gestational age (SGA) live births. PIMS main hypotheses are that ART initiation in pregnancy and ART-induced hypertension are associated with PTD and SGA respectively and that reconstitution of cellular immune responses in women on ART from before pregnancy results in increases in PTD of GA infants. PARTICIPANTS: Pregnant women (n=3972) aged ≥18 years regardless of HIV status recruited from 2015 to 2016 into the overall PIMS cohort (2517 HIV-negative, 1455 living with HIV). A nested cohort contained 551 women living with HIV who were ≤24 weeks’ GA on ultrasound: 261 initiated ART before pregnancy, 290 initiated during the pregnancy. FINDINGS TO DATE: Women in the overall cohort were followed antenatally through to delivery using routine clinical records; further women in the nested cohort were actively followed up until 12 months post partum, with data collected on maternal health (HIV care and ART use, clinical care and intercurrent clinical history). Other procedures conducted on the nested cohort included physical examinations (anthropometry, blood pressure measurement), assessment of fetal growth (ultrasound), maternal and infant phlebotomy for storage of plasma, RNA and peripheral blood mononuclear cells, collection of delivery specimens (placenta and cord blood) and infant 12-month developmental assessment. Preliminary findings have contributed to our understanding of risk factors for adverse birth outcomes, and the relationship between pregnancy immunology, HIV/ART and adverse birth outcomes. FUTURE PLANS: Using specimens collected from study participants living with HIV throughout pregnancy and first year of life, the PIMS provides a valuable platform for answering a variety of research questions focused on temporal changes of immunology markers in women whose immune status is altered by HIV infection, and how ART initiated during the pregnancy affects immune responses. The relationship between these immunological changes with adverse birth outcomes as well as possible longer-term impact of exposure to ART in fetal and early life will be explored. Additionally, further active and passive follow-up of mothers and their infants is planned at school-going age and beyond to chart growth, morbidity and development, as well as changes in family circumstances.
format Online
Article
Text
id pubmed-8487191
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-84871912021-10-22 Cohort profile: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS) Malaba, Thokozile R Myer, Landon Gray, Clive Newell, Marie-Louise BMJ Open Public Health PURPOSE: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS) is a prospective cohort study in South Africa investigating the association between antiretroviral therapy (ART) use, preterm delivery (PTD) and small-for-gestational age (SGA) live births. PIMS main hypotheses are that ART initiation in pregnancy and ART-induced hypertension are associated with PTD and SGA respectively and that reconstitution of cellular immune responses in women on ART from before pregnancy results in increases in PTD of GA infants. PARTICIPANTS: Pregnant women (n=3972) aged ≥18 years regardless of HIV status recruited from 2015 to 2016 into the overall PIMS cohort (2517 HIV-negative, 1455 living with HIV). A nested cohort contained 551 women living with HIV who were ≤24 weeks’ GA on ultrasound: 261 initiated ART before pregnancy, 290 initiated during the pregnancy. FINDINGS TO DATE: Women in the overall cohort were followed antenatally through to delivery using routine clinical records; further women in the nested cohort were actively followed up until 12 months post partum, with data collected on maternal health (HIV care and ART use, clinical care and intercurrent clinical history). Other procedures conducted on the nested cohort included physical examinations (anthropometry, blood pressure measurement), assessment of fetal growth (ultrasound), maternal and infant phlebotomy for storage of plasma, RNA and peripheral blood mononuclear cells, collection of delivery specimens (placenta and cord blood) and infant 12-month developmental assessment. Preliminary findings have contributed to our understanding of risk factors for adverse birth outcomes, and the relationship between pregnancy immunology, HIV/ART and adverse birth outcomes. FUTURE PLANS: Using specimens collected from study participants living with HIV throughout pregnancy and first year of life, the PIMS provides a valuable platform for answering a variety of research questions focused on temporal changes of immunology markers in women whose immune status is altered by HIV infection, and how ART initiated during the pregnancy affects immune responses. The relationship between these immunological changes with adverse birth outcomes as well as possible longer-term impact of exposure to ART in fetal and early life will be explored. Additionally, further active and passive follow-up of mothers and their infants is planned at school-going age and beyond to chart growth, morbidity and development, as well as changes in family circumstances. BMJ Publishing Group 2021-09-30 /pmc/articles/PMC8487191/ /pubmed/34593488 http://dx.doi.org/10.1136/bmjopen-2020-047133 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Public Health
Malaba, Thokozile R
Myer, Landon
Gray, Clive
Newell, Marie-Louise
Cohort profile: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS)
title Cohort profile: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS)
title_full Cohort profile: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS)
title_fullStr Cohort profile: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS)
title_full_unstemmed Cohort profile: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS)
title_short Cohort profile: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS)
title_sort cohort profile: prematurity immunology in mothers living with hiv and their infants study (pims)
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487191/
https://www.ncbi.nlm.nih.gov/pubmed/34593488
http://dx.doi.org/10.1136/bmjopen-2020-047133
work_keys_str_mv AT malabathokoziler cohortprofileprematurityimmunologyinmotherslivingwithhivandtheirinfantsstudypims
AT myerlandon cohortprofileprematurityimmunologyinmotherslivingwithhivandtheirinfantsstudypims
AT grayclive cohortprofileprematurityimmunologyinmotherslivingwithhivandtheirinfantsstudypims
AT newellmarielouise cohortprofileprematurityimmunologyinmotherslivingwithhivandtheirinfantsstudypims